May 26, 2022

Optellum team amongst innovators attending the American Association for Thoracic Surgery 102nd annual meeting

Back in person for the first time since 2019, the Optellum team reunited with surgeons and thought leaders attending the 102nd Annual Meeting of the American Association for Thoracic Surgery (AATS) in Boston.

The theme for this year’s meeting was ‘innovation’, which presented attendees with the opportunity to discuss and build upon new ways of working together towards advancing patient care. The Optellum team engaged in exciting conversations, forming new relationships with clinical connections, and demonstrated the Virtual Nodule Clinic for early Lung Cancer Prediction at our booth.

During that same weekend, other members of the Optellum team flew to San Francisco to attend the American Thoracic Society (ATS) international conference, where they joined clinical presentations and met with some of our US partners in the city.

As we approach the second half of 2022, Optellum is looking ahead to a busy calendar and preparing our presence for upcoming meetings and conferences including: the European Congress of Radiology (ECR) in July, the 2022 World Conference on Lung Cancer (WCLC) in August and the CHEST annual meeting in October. We hope to see you there and we are taking advanced bookings for in-person demonstrations of the Virtual Nodule Clinic. To secure your place, please contact our sales team.

Recent posts

August 24, 2026 / News & Press, Partnerships
SimonMed Launches World’s First Seamlessly Integrated AI Lung Nodule Risk Assessment Workflow
SimonMed is creating the first fully automated AI-powered lung cancer risk assessment workflow deployed at enterprise scale, combining multiple FDA-cleared AI technologies into a...
Read more
August 13, 2026 / News & Press, Partnerships
Coreline Soft and Optellum announce intent to collaborate to advance AI...
Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform
Read more
June 15, 2026 / News & Press, Partnerships
Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated...
Optellum announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive innovations to reduce waiting...
Read more
Optellum is trusted by industry & academic leaders
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
Certification
Redefining early intervention of lung disease starting with one of the deadliest, lung cancer
Contact us